WallStSmart

Ardent Health Partners, Inc. (ARDT)vsThe Ensign Group Inc (ENSG)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

Ardent Health Partners, Inc. generates 25% more annual revenue ($6.32B vs $5.06B). ENSG leads profitability with a 6.8% profit margin vs 2.1%. ARDT trades at a lower P/E of 8.8x. ENSG earns a higher WallStSmart Score of 57/100 (C).

ARDT

Hold

45

out of 100

Grade: D+

Growth: 3.3Profit: 5.5Value: 5.7Quality: 8.5
Piotroski: 6/9Altman Z: 2.08

ENSG

Buy

57

out of 100

Grade: C

Growth: 8.0Profit: 6.0Value: 8.0Quality: 5.8
Piotroski: 5/9Altman Z: 2.34
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

ARDTSignificantly Overvalued (-43.2%)

Margin of Safety

-43.2%

Fair Value

$6.53

Current Price

$8.78

$2.25 premium

UndervaluedFair: $6.53Overvalued
ENSGFair Value (-0.3%)

Margin of Safety

-0.3%

Fair Value

$211.28

Current Price

$203.89

$7.39 premium

UndervaluedFair: $211.28Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

ARDT2 strengths · Avg: 10.0/10
P/E RatioValuation
8.8x10/10

Attractively priced relative to earnings

Price/BookValuation
1.0x10/10

Reasonable price relative to book value

ENSG1 strengths · Avg: 8.0/10
Revenue GrowthGrowth
20.2%8/10

Revenue surging 20.2% year-over-year

Areas to Watch

ARDT4 concerns · Avg: 2.8/10
Market CapQuality
$1.21B3/10

Smaller company, higher risk/reward

Profit MarginProfitability
2.1%3/10

2.1% margin — thin

Debt/EquityHealth
1.843/10

Elevated debt levels

Revenue GrowthGrowth
-0.1%2/10

Revenue declined 0.1%

ENSG3 concerns · Avg: 3.7/10
PEG RatioValuation
1.784/10

Expensive relative to growth rate

P/E RatioValuation
35.0x4/10

Premium valuation, high expectations priced in

Profit MarginProfitability
6.8%3/10

6.8% margin — thin

Comparative Analysis Report

WallStSmart Research

Bull Case : ARDT

The strongest argument for ARDT centers on P/E Ratio, Price/Book.

Bull Case : ENSG

The strongest argument for ENSG centers on Revenue Growth. Revenue growth of 20.2% demonstrates continued momentum.

Bear Case : ARDT

The primary concerns for ARDT are Market Cap, Profit Margin, Debt/Equity. Debt-to-equity of 1.84 is elevated, increasing financial risk. Thin 2.1% margins leave little buffer for downturns.

Bear Case : ENSG

The primary concerns for ENSG are PEG Ratio, P/E Ratio, Profit Margin.

Key Dynamics to Monitor

ARDT profiles as a value stock while ENSG is a growth play — different risk/reward profiles.

ENSG is growing revenue faster at 20.2% — sustainability is the question.

ARDT generates stronger free cash flow (138M), providing more financial flexibility.

Monitor MEDICAL CARE FACILITIES industry trends, competitive dynamics, and regulatory changes.

Bottom Line

ENSG scores higher overall (57/100 vs 45/100) and 20.2% revenue growth. Both earn "Buy" and "Hold" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Ardent Health Partners, Inc.

HEALTHCARE · MEDICAL CARE FACILITIES · USA

Ardent Health Partners, Inc., based in Nashville, Tennessee, is a leading healthcare organization dedicated to providing high-quality, patient-centered care through its extensive network of hospitals and outpatient facilities. The company's strong portfolio of acute care hospitals is complemented by its commitment to innovation in healthcare solutions, allowing it to effectively address the evolving needs of diverse communities. With a robust financial framework, Ardent is strategically poised for growth, aiming to improve healthcare access and outcomes while skillfully navigating the complexities of the contemporary healthcare environment.

Visit Website →

The Ensign Group Inc

HEALTHCARE · MEDICAL CARE FACILITIES · USA

The Ensign Group, Inc. provides health care services in the post-acute care continuum and other ancillary businesses. The company is headquartered in San Juan Capistrano, California.

Want to dig deeper into these stocks?